These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30843890)

  • 41. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    Suzuki K; Nakazato T; Sanada Y; Mihara A; Tachikawa N; Kurai H; Yoshimura Y; Hayashi H; Yoshida S; Kakimoto T
    Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving outcomes for patients with Burkitt lymphoma and HIV.
    Blinder VS; Chadburn A; Furman RR; Mathew S; Leonard JP
    AIDS Patient Care STDS; 2008 Mar; 22(3):175-87. PubMed ID: 18290753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical history, lifestyle, family history, and occupational risk factors for sporadic Burkitt lymphoma/leukemia: the Interlymph Non-Hodgkin Lymphoma Subtypes Project.
    Mbulaiteye SM; Morton LM; Sampson JN; Chang ET; Costas L; de Sanjosé S; Lightfoot T; Kelly J; Friedberg JW; Cozen W; Marcos-Gragera R; Slager SL; Birmann BM; Weisenburger DD
    J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):106-14. PubMed ID: 25174031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma.
    Zhang XY; Liang JH; Wang L; Zhu HY; Wu W; Cao L; Fan L; Li JY; Xu W
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):117-127. PubMed ID: 30327941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting.
    Hesseling P; Israels T; Harif M; Chantada G; Molyneux E;
    Pediatr Blood Cancer; 2013 Mar; 60(3):357-62. PubMed ID: 23192950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens.
    Carey CD; Gusenleitner D; Chapuy B; Kovach AE; Kluk MJ; Sun HH; Crossland RE; Bacon CM; Rand V; Dal Cin P; Le LP; Neuberg D; Sohani AR; Shipp MA; Monti S; Rodig SJ
    J Mol Diagn; 2015 Jan; 17(1):19-30. PubMed ID: 25468432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Burkitt lymphoma mimicking acute pancreatitis.
    Bacchi LM; Ucella I; Amancio TT; Gonçalves MC; Palhares RB; Siqueira SAC
    Autops Case Rep; 2012; 2(3):5-11. PubMed ID: 31528574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy.
    Reddy P; Kanan S; Cowan A; Warren H; Till B; Shadman M; Cassaday R; Press O; Shustov A; Gopal A; Smith SD
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e87-e90. PubMed ID: 28870643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.
    Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH
    Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Burkitt lymphoma/leukemia: improving prognosis.
    Kenkre VP; Stock W
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S231-8. PubMed ID: 19778846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIV-associated lymphoma.
    Kaplan LD
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):101-17. PubMed ID: 22409827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.
    Choi MK; Jun HJ; Lee SY; Kim KH; Lim DH; Kim K; Ko YH; Kim WS; Kim SJ
    Ann Hematol; 2009 Nov; 88(11):1099-106. PubMed ID: 19288103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
    Mohamedbhai SG; Sibson K; Marafioti T; Kayani I; Lowry L; Goldstone AH; Linch DC; Ardeshna KM
    Br J Haematol; 2011 Jan; 152(2):175-81. PubMed ID: 21092025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics and diffuse large B-Cell lymphoma.
    Niroula R; Butera J
    R I Med J (2013); 2015 Nov; 98(11):23-6. PubMed ID: 26517251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EBV-associated Burkitt lymphoma in Taiwan is not age-related.
    Chen BJ; Chang ST; Weng SF; Huang WT; Chu PY; Hsieh PP; Jung YC; Kuo CC; Chuang YT; Chuang SS
    Leuk Lymphoma; 2016; 57(3):644-53. PubMed ID: 26422188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
    Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
    Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term follow-up of dose-adjusted EPOCH plus rituximab (DA-EPOCH-R) in untreated patients with poor prognosis large B-cell lymphoma. A phase II study conducted by the Spanish PETHEMA Group.
    Purroy N; Bergua J; Gallur L; Prieto J; Lopez LA; Sancho JM; García-Marco JA; Castellví J; Montes-Moreno S; Batlle A; de Villambrosia SG; Carnicero F; Ferrando-Lamana L; Piris MA; Lopez A
    Br J Haematol; 2015 Apr; 169(2):188-98. PubMed ID: 25521006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
    De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
    Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.